Toshiaki Yoshikawa

机构：National Cancer Center Hospital East · ORCID：0000-0002-9785-2968

发表论文 102 篇 · 总被引 2185 次 · h-index 25

代表论文

• Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy (2021 · Blood · 被引 136)
• Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer (2021 · Genome biology · 被引 115)
• Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis (2020 · Cancer Science · 被引 41)
• First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors (2019 · Journal for ImmunoTherapy of Cancer · 被引 35)
• Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial (2019 · Cancer Science · 被引 32)
• Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells (2024 · Cell Reports Medicine · 被引 25)